Summary of Significant Accounting Policies - Segments (Details) $ in Thousands	6 Months Ended	12 Months Ended
	Dec. 31, 2016 USD ($) item	Jun. 30, 2016 USD ($)	Jun. 30, 2015 USD ($)	Jun. 30, 2014
Segment Information
Number of operating segments | item	1
Recent Accounting Pronouncements
Prepaid and other current assets	$ 5,386	$ 4,881	$ 4,175
Other assets	$ 3,020	$ 3,430	$ 974
Bayer | Revenues percentage | Customer concentration
Segment Information
Percentages of revenue recognized		17.00%
Lilly | Revenues percentage | Customer concentration
Segment Information
Percentages of revenue recognized	4.00%	11.00%	21.00%	18.00%
Novartis | Revenues percentage | Customer concentration
Segment Information
Percentages of revenue recognized	24.00%	1.00%	43.00%	38.00%
Roche | Revenues percentage | Customer concentration
Segment Information
Percentages of revenue recognized	60.00%	43.00%	23.00%	34.00%
Takeda | Revenues percentage | Customer concentration
Segment Information
Percentages of revenue recognized	8.00%	16.00%
Adjustment | Accounting Standards Update 2015-03
Recent Accounting Pronouncements
Prepaid and other current assets		$ (1,000)	$ (1,200)
Other assets		$ (6,800)	$ (4,400)
Maximum | Accounting Standards Update 2014-09
Recent Accounting Pronouncements
Number of contracts requiring evaluation | item	10